MedTrace Logo

Thigh Circumference Reduction Study

NCT00953290 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2011-05-10

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the Cutera radio frequency (RF) device for the new indication of reduction of thigh circumference.

Conditions

  • Reduction of Localized Excess Fat

Interventions

DEVICE

Cutera Radio Frequency Device

Up to three treatments, one pass, dosage range of 15-60 kJ.

Sponsors & Collaborators

  • Cutera Inc.

    lead INDUSTRY

Principal Investigators

  • Stephen J. Ronan, MD

  • Jacqueline Calkin, MD

  • Christine Lee, MD

  • Scott Kramer, MD

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2010-01-31
Completion
2010-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00953290 on ClinicalTrials.gov